Skip to content
  • The Initial Investment in South Wales Contract Manufacturing Facility Will Produce 1.2 Million Rapid Covid Tests Daily
  • The Investment Will Create Approx. 300 New Jobs in the Welsh Valleys
  • Innova Plans to Boost UK Local Production Capacity Through Further Investments Later This Year

May 26, 2021 – Pasadena, CA, USA and Caerphilly, South Wales, UK) Innova Medical Group, the world’s largest provider of rapid antigen tests, has announced an initial investment in South Wales to start producing millions of COVID lateral flow tests per day in the UK, with additional investments to follow later this year to further expand production capacity.

Through a partnership with Sharp Packaging, part of UDG Healthcare PLC, and a global leader in contract packaging and clinical services, Innova’s investment will add approximately 300 new jobs across South Wales. The investment will see the delivery of the initial packaging machinery at the Rhymney facility at the end of June, with production expected to begin in early July.

“Innova understands the importance of speed in the fight against the pandemic and strategic contract manufacturing allows us to start local production quickly,” said Daniel Elliott, President and CEO of Innova Medical Group. “By domestically sourcing as much of the processes as possible, we are confident this partnership with Sharp will deliver value to our UK customers. We look forward to the launch of Innova’s lateral flow test production in Wales and to expanding that into other markets and regions across the UK.”

Daniel Elliott, President of CEO of Innova Medical Group

The Rhymney operation will be one of the largest facilities of its kind and the first to produce Innova’s lateral flow tests in the United Kingdom. Innova expects the production capacity from the Welsh facility will fill a significant amount of the central government’s future demand.

“We are delighted to collaborate with Innova to support the manufacturing of its COVID-19 lateral flow test kits, right here in the UK where they’ll be used,” said Ian Morgan, General Manager, Sharp UK. “This important partnership not only allows us to expand our facility by a third but will add over 200 new jobs, providing much needed opportunities for our local community.”

Ian Morgan, Sharp UK General Manager

Vaughan Gething, Economy Minister of Wales said: “Wales welcomes Innova’s investment and the hundreds of new job opportunities it creates, boosting the local economy and further enhancing Wales’ reputation in the life sciences sector.”

Gerald Jones MP, Member of Parliament for Merthyr Tydfil and Rhymney, added: “Rhymney and the surrounding communities are a great place to establish a business and I look forward to Innova and Sharp being a key part of our community for many more years to come.”

The official and exclusive distributor for Innova rapid antigen tests in the UK is

Sharp contact

Alison Dillon
Marketing Communications Manager
Tel: +353-87-146-8522

Our team based in Rhymney, South Wales is looking for a #ProposalsWriter to work closely with the business development teams in the preparation of proposals for new business.

Click here to learn more and to apply:


We are pleased to announce that the @AlliancetoZero has won the Environmental Impact award presented by the Pharmaceutical Technology Excellence Awards.

Click the link to download the digital awards report:

#sustainability #netzero #climateaction #pharma

In this blog, Ria Rhemrev-Boom, lead EU QP for Sharp, comments on how the role of a QP has changed over time and reveals how Sharp has adapted to manage the increased burden assigned to QPs.

Click here to read the full blog: